384 related articles for article (PubMed ID: 30338649)
21. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
Chen YM; Chen HH; Huang WN; Chen YH; Hsieh TY; Yang SS; Lan JL; Chen DY
Int J Rheum Dis; 2019 Jun; 22(6):1145-1151. PubMed ID: 31117160
[TBL] [Abstract][Full Text] [Related]
22. Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity.
Solay AH; Acar A; Eser F; Kuşcu F; Tütüncü EE; Kul G; Şentürk GÇ; Gürbüz Y
Turk J Gastroenterol; 2018 Sep; 29(5):561-565. PubMed ID: 30260778
[TBL] [Abstract][Full Text] [Related]
23. Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.
Kuo MH; Tseng CW; Lu MC; Tung CH; Tseng KC; Huang KY; Lee CH; Lai NS
Dig Dis Sci; 2021 Nov; 66(11):4026-4034. PubMed ID: 33387124
[TBL] [Abstract][Full Text] [Related]
24. The role of anti-HBs in hepatitis B reactivation during direct-acting antiviral therapy for chronic hepatitis C.
Spaan M; Bruce M; Agarwal K; Carey I
Antivir Ther; 2018; 23(6):539-542. PubMed ID: 30309997
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients.
Urata Y; Uesato R; Tanaka D; Kowatari K; Nitobe T; Nakamura Y; Motomura S
Mod Rheumatol; 2011 Feb; 21(1):16-23. PubMed ID: 20668905
[TBL] [Abstract][Full Text] [Related]
26. Efficient Prophylactic Management of HBV Reactivation by an Information Technology Encoding System: Results of a 6-year Prospective Cohort Study.
Notsumata K; Nomura Y; Tanaka A; Nomura Y; Ueda T; Sanada T; Watanabe H; Toya D
Intern Med; 2020; 59(20):2457-2464. PubMed ID: 33055468
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan.
Fujita M; Sugiyama M; Sato Y; Nagashima K; Takahashi S; Mizokami M; Hata A
J Viral Hepat; 2018 Nov; 25(11):1312-1320. PubMed ID: 29770539
[TBL] [Abstract][Full Text] [Related]
28. Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.
Schwaneck EC; Krone M; Kreissl-Kemmer S; Weißbrich B; Weiss J; Tony HP; Gadeholt O; Schmalzing M; Geier A
Clin Rheumatol; 2018 Nov; 37(11):2963-2970. PubMed ID: 30238380
[TBL] [Abstract][Full Text] [Related]
29. Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice.
Mo YQ; Liang AQ; Ma JD; Chen LF; Zheng DH; Schumacher HR; Dai L
BMC Musculoskelet Disord; 2014 Dec; 15():449. PubMed ID: 25532827
[TBL] [Abstract][Full Text] [Related]
30. Risk of hepatitis B reactivation in patients receiving anti-tumor necrosis factor-α therapy.
Fidan S; Capkın E; Arıca DA; Durak S; Okatan IE
Int J Rheum Dis; 2021 Feb; 24(2):254-259. PubMed ID: 33244900
[TBL] [Abstract][Full Text] [Related]
31. Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study.
Papalopoulos I; Fanouriakis A; Kougkas N; Flouri I; Sourvinos G; Bertsias G; Repa A; Avgoustidis N; Sidiropoulos P
Clin Exp Rheumatol; 2018; 36(1):102-109. PubMed ID: 28850029
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
Su YC; Lin PC; Yu HC; Wu CC
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
[TBL] [Abstract][Full Text] [Related]
33. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
Vassilopoulos D; Apostolopoulou A; Hadziyannis E; Papatheodoridis GV; Manolakopoulos S; Koskinas J; Manesis EK; Archimandritis AI
Ann Rheum Dis; 2010 Jul; 69(7):1352-5. PubMed ID: 20472596
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus reactivation in kidney transplant patients with resolved hepatitis B virus infection: Risk factors and the safety and efficacy of preemptive therapy.
Mei T; Noguchi H; Hisadome Y; Kaku K; Nishiki T; Okabe Y; Nakamura M
Transpl Infect Dis; 2020 Apr; 22(2):e13234. PubMed ID: 31856328
[TBL] [Abstract][Full Text] [Related]
35. Practice Pattern of Hepatitis B Testing in Rheumatoid Arthritis Patients: A Cross-National Comparison Between the US and Taiwan.
Lin TC; Hashemi N; Kim SC; Yang YK; Yoshida K; Tedeschi S; Desai R; Solomon DH
Arthritis Care Res (Hoboken); 2018 Jan; 70(1):30-38. PubMed ID: 28320050
[TBL] [Abstract][Full Text] [Related]
36. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.
Yang HC; Tsou HH; Pei SN; Chang CS; Chen JH; Yao M; Lin SJ; Lin J; Yuan Q; Xia N; Liu TW; Chen PJ; Cheng AL; Hsu C;
J Hepatol; 2018 Aug; 69(2):286-292. PubMed ID: 29551710
[TBL] [Abstract][Full Text] [Related]
37. Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis.
Tien YC; Yen HH; Chiu YM
Clin Exp Rheumatol; 2017; 35(5):831-836. PubMed ID: 28375829
[TBL] [Abstract][Full Text] [Related]
38. Risk-stratified management strategies for HBV reactivation in RA patients receiving biological and targeted therapy: A narrative review.
Chen YM; Yang SS; Chen DY
J Microbiol Immunol Infect; 2019 Feb; 52(1):1-8. PubMed ID: 29158080
[TBL] [Abstract][Full Text] [Related]
39. Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs.
Mori S
Mod Rheumatol; 2011 Dec; 21(6):621-7. PubMed ID: 21528424
[TBL] [Abstract][Full Text] [Related]
40. Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection.
Kanaan N; Kabamba B; Maréchal C; Pirson Y; Beguin C; Goffin E; Hassoun Z
J Clin Virol; 2012 Nov; 55(3):233-8. PubMed ID: 22921412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
